logo

For the Inventor, By the Inventor

Research Triangle Park, NC, United States of America

Athenix Corporation


USPTO Granted Patents = 86

% Expired Patents = 33.7



Forward Citations = 454

Loading Chart...
Loading Chart...

34 inventors (with patents filed for the assignee):

goldMedal Nicholas B Duck (34 out of 57 patents)

silverMedal Kimberly S Sampson (30 out of 39 patents)

bronzeMedal Daniel John Tomso (29 out of 34 patents)

4.  Nadine B Carozzi (24 out of 31 patents)

5.  Michael G Koziel (23 out of 71 patents)

6.  Tracy Hargiss (21 out of 21 patents)

7.  Brian S Carr (20 out of 81 patents)

8.  Brian Vande Berg (15 out of 19 patents)

9.  Volker Heinrichs (14 out of 17 patents)

10.  Philip E Hammer (14 out of 37 patents)

11.  Laura Cooper Schouten (12 out of 15 patents)

12.  Cheryl Peters (11 out of 17 patents)

13.  Duane Alan Lehtinen (10 out of 22 patents)

14.  Todd K Hinson (9 out of 9 patents)

15.  Nalini M Desai (9 out of 37 patents)


Core Competencies:
Delta-Endotoxin
Pesticidal Genes
EPSP Synthase
Insecticidal Proteins
Herbicide Resistance
Nematode Toxins
Gene Design
Biotechnology
Transgenic Plants
Genetic Diversity
Synthetic Genes
Variant Proteins

86 patents:

1. 10221431 - AXMI422 toxin gene and methods for its use (2019-03-05),
2. 10059960 - AXMI221z, AXMI222z, AXMI223z, AXMI224z, and AXMI225z delta-endotoxin genes and methods for their use (2018-08-28),
3. 9982274 - AXMI115 variant insecticidal gene and methods for its use (2018-05-29),
4. 9909140 - AXMI-115, AXMI-113, AXMI-005, AXMI-163 and AXMI-184: insecticidal proteins and methods for their use (2018-03-06),
5. 9862967 - AXMI281 toxin gene and methods for its use (2018-01-09),
6. 9862965 - AXMI205 variant proteins and methods of use (2018-01-09),
7. 9790258 - AXMI335 toxin gene and methods for its use (2017-10-17),
8. 9758793 - AXMI-234 and AXMI-235 delta-endotoxin genes and methods for their use (2017-09-12),
9. 9752158 - AXMI115 variant insecticidal gene and methods for its use (2017-09-05),
10. 9725735 - AXMI345 delta-endotoxin gene and methods for its use (2017-08-08),
11. 9695440 - AXMI232, AXMI233, and AXMI249 toxin genes and methods for their use (2017-07-04),
12. 9556255 - Toxin genes and methods for their use (2017-01-31),
13. 9528122 - Axmi270 toxin gene and methods of use (2016-12-27),
14. 9321814 - AXMI238 toxin gene and methods for its use (2016-04-26),
15. 9260487 - AXMI-205 pesticidal gene and method for its use (2016-02-16),
Company Overview
Athenix Corporation, based in Research Triangle Park, NC, specializes in the development of innovative pesticidal genes aimed at enhancing agricultural productivity. The company focuses on core technologies such as Delta-Endotoxin and insecticidal proteins, which are pivotal in creating effective pest control solutions. Additionally, Athenix is engaged in research related to herbicide resistance and nematode toxins, leveraging advanced gene design and biotechnology to address challenges in crop protection and sustainability.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Athenix Corporation USPTO Patent Assignee Logo
86 Patents

#9 in Research Triangle Park, NC

#109 in North Carolina

#4,338 in US

#8,873 in the World

Research Triangle Park, NC (US)
Research Triangle Park, NC, United States of America

Athenix Corporation

Forward Citations = 454

34 inventors:

goldMedal Nicholas B Duck (34 out of 57 patents)

silverMedal Kimberly S Sampson (30 out of 39 patents)

bronzeMedal Daniel John Tomso (29 out of 34 patents)

4.  Nadine B Carozzi (24 out of 31 patents)

5.  Michael G Koziel (23 out of 71 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Athenix Corporation. Retrieved from https://idiyas.com/company/athenix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…